Incontinence Research Today is a free monthly online journal that collates and summarizes the latest research about Incontinence, including details on urinary incontinence, bladder control, treatment, causes.

Volume 2 (2005), Issue 6 (June)

1. High prevalence of incontinence among young adults with spina bifida: description, prediction and problem perception.
   Spinal Cord, 43(6): 331-40. [Abstract] [Full-text]
2. Long-term safety, tolerability and efficacy of extended-release tolterodine in the treatment of overactive bladder in Japanese patients.
   Int J Urol, 12(5): 456-64. [Abstract] [Full-text]
3. Indwelling catheter use in home care: elderly, aged 65+, in 11 different countries in Europe.
   Age Ageing, 34(4): 377-81. [Abstract] [Full-text]
4. Porcine small intestinal submucosa as a percutaneous mid-urethral sling: 2-year results.
   BJU Int, 96(1): 103-6. [Abstract] [Full-text]
5. Urethral sensitivity in incontinent women.
   Eur Urol, 48(1): 116-20. [Abstract] [Full-text]
6. Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder.
   Eur Urol, 48(1): 110-5. [Abstract] [Full-text]
7. Comparison of darifenacin and oxybutynin in patients with overactive bladder: assessment of ambulatory urodynamics and impact on salivary flow.
   Eur Urol, 48(1): 102-9. [Abstract] [Full-text]
8. The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis.
   Eur Urol, 48(1): 5-26. [Abstract] [Full-text]
9. Comparison of the quality of life after nonsurgical radiofrequency energy tissue micro-remodeling in premenopausal and postmenopausal women with moderate-to-severe stress urinary incontinence.
   Am J Obstet Gynecol, 192(6): 1995-8; discussion 1999-2001. [Abstract] [Full-text]
10. Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial.
    Am J Obstet Gynecol, 192(6): 1849-54; discussion 1854-5. [Abstract] [Full-text]
11. Vulvar disease: a pelvic floor pain disorder?
    Am J Obstet Gynecol, 192(6): 1829-34; discussion 1834-5. [Abstract] [Full-text]
12. Is it possible to make cross-study comparisons of urinary continence rates in patients with overactive bladder?
    Curr Med Res Opin, 21(6): 835-7. [Abstract] [Full-text]
13. Trospium chloride for the treatment of overactive bladder with urge incontinence.
    Clin Ther, 27(5): 511-30. [Abstract] [Full-text]
14. Markers of collagen synthesis and degradation in urogenital tissue from women with and without stress urinary incontinence.
    Neurourol Urodyn, 24(4): 319-24. [Abstract] [Full-text]
15. Factors influencing self-perceived disease severity in women with stress urinary incontinence combined with or without urge incontinence.
    Neurourol Urodyn, 24(4): 341-7. [Abstract] [Full-text]
16. Pelvic floor muscle training is effective in women with urinary incontinence after stroke: a randomised, controlled and blinded study.
    Neurourol Urodyn, 24(4): 348-57. [Abstract] [Full-text]

© 2004-2008 Incontinence Research Today. All Rights Reserved.